191 related articles for article (PubMed ID: 26622418)
1. Prognostic significance of the mRNA expression of
Sun S; Shi W; Wu Z; Zhang G; Yang BO; Jiao S
Exp Ther Med; 2015 Sep; 10(3):937-941. PubMed ID: 26622418
[TBL] [Abstract][Full Text] [Related]
2. Expression of ERCC1, TYMS, RRM1, TUBB3, non-muscle myosin II, myoglobin and MyoD1 in lung adenocarcinoma pleural effusions predicts survival in patients receiving platinum-based chemotherapy.
Jiang H; Wang H; Wang S; Pei Z; Fu Z; Fang C; Wang J; Lu Q; Wang E; Li J
Mol Med Rep; 2015 May; 11(5):3523-32. PubMed ID: 25573098
[TBL] [Abstract][Full Text] [Related]
3. mRNA expression and clinical significance of ERCC1, BRCA1, RRM1, TYMS and TUBB3 in postoperative patients with non-small cell lung cancer.
Han Y; Wang XB; Xiao N; Liu ZD
Asian Pac J Cancer Prev; 2013; 14(5):2987-90. PubMed ID: 23803067
[TBL] [Abstract][Full Text] [Related]
4. Extensive analysis of the molecular biomarkers excision repair cross complementing 1, ribonucleotide reductase M1, β-tubulin III, thymidylate synthetase, and topoisomerase IIα in breast cancer: Association with clinicopathological characteristics.
Li J; Sun P; Huang T; He S; Li L; Xue G
Medicine (Baltimore); 2021 Apr; 100(14):e25344. PubMed ID: 33832110
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of rearrangement of ALK, ROS1, somatic mutation of EGFR, KRAS, BRAF, PIK3CA, and mRNA expression of ERCC1, TYMS, RRM1, TUBB3, EGFR in patients with non-small cell lung cancer and their clinical significance.
Zhang Q; Sun T; Kang P; Qian K; Deng B; Zhou J; Wang R; Jiang B; Li K; Liu F; Wu S; Tan Q
Cancer Chemother Pharmacol; 2016 Mar; 77(3):583-93. PubMed ID: 26842788
[TBL] [Abstract][Full Text] [Related]
6. Expression of ERCC1, TYMS, TUBB3, RRM1 and TOP2A in patients with esophageal squamous cell carcinoma: A hierarchical clustering analysis.
Yu Y; Ding S; Liang Y; Zheng Y; Li W; Yang L; Zheng X; Jiang J
Exp Ther Med; 2014 Jun; 7(6):1578-1582. PubMed ID: 24926347
[TBL] [Abstract][Full Text] [Related]
7. Mutations of EGFR or KRAS and expression of chemotherapy-related genes based on small biopsy samples in stage IIIB and IV inoperable non-small cell lung cancer.
Deng LL; Deng HB; Lu CL; Guo Y; Wang D; Yan CH; Lv X; Shao YX
J Cancer Res Clin Oncol; 2014 Dec; 140(12):2097-105. PubMed ID: 24994038
[TBL] [Abstract][Full Text] [Related]
8. Analysis of ERCC1, BRCA1, RRM1 and TUBB3 as predictors of prognosis in patients with non-small cell lung cancer who received cisplatin-based adjuvant chemotherapy: A prospective study.
Huang ZL; Cao X; Luo RZ; Chen YF; Zhu LC; Wen Z
Oncol Lett; 2016 Jan; 11(1):299-305. PubMed ID: 26870207
[TBL] [Abstract][Full Text] [Related]
9. Gene expression profiles of ERCC1, TYMS, RRM1, TUBB3 and EGFR in tumor tissue from non-small cell lung cancer patients.
Yu D; Li J; Han Y; Liu S; Xiao N; Li Y; Sun X; Liu Z
Chin Med J (Engl); 2014; 127(8):1464-8. PubMed ID: 24762590
[TBL] [Abstract][Full Text] [Related]
10. Combined analysis of mRNA expression of ERCC1, BAG-1, BRCA1, RRM1 and TUBB3 to predict prognosis in patients with non-small cell lung cancer who received adjuvant chemotherapy.
Leng XF; Chen MW; Xian L; Dai L; Ma GY; Li MH
J Exp Clin Cancer Res; 2012 Mar; 31(1):25. PubMed ID: 22439756
[TBL] [Abstract][Full Text] [Related]
11.
Guo N; Zhang W; Zhang B; Li Y; Tang J; Li S; Zhao Y; Zhao Y; Xia H; Yu C
Mol Clin Oncol; 2015 Sep; 3(5):1123-1128. PubMed ID: 26623063
[TBL] [Abstract][Full Text] [Related]
12. [Expression and predictive role of excision repair cross complementation group 1, ribonucleotide reductase subunit M1, and β-tubulin 3 in postoperative patients with non-small cell lung cancer receiving adjuvant chemotherapy].
Shi Y; Chen L; Li J; Lü YL; Jiao SC
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2010 Aug; 32(4):375-82. PubMed ID: 20868593
[TBL] [Abstract][Full Text] [Related]
13. Customized Adjuvant Chemotherapy Based on Biomarker Examination May Improve Survival of Patients Completely Resected for Non-small-cell Lung Cancer.
Liu D; Nakashima N; Nakano J; Tarumi S; Matsuura N; Nakano T; Nii K; Tokunaga Y; Go T; Yokomise H
Anticancer Res; 2017 May; 37(5):2501-2507. PubMed ID: 28476819
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of UGT1A1 polymorphism and expression of ERCC1, BRCA1, TYMS, RRM1, TUBB3, STMN1 and TOP2A in gastric cancer.
Cao Y; Zhang G; Wang P; Zhou J; Gan W; Song Y; Huang L; Zhang Y; Luo G; Gong J; Zhang L
BMC Gastroenterol; 2017 Jan; 17(1):2. PubMed ID: 28056823
[TBL] [Abstract][Full Text] [Related]
15. Individualized chemotherapy guided by the expression of
Li J; Sun P; Huang T; He S; Li L; Xue G
Oncol Lett; 2021 Jan; 21(1):21. PubMed ID: 33240427
[No Abstract] [Full Text] [Related]
16. The prognostic value of ERCC1 and RRM1 gene expression in completely resected non-small cell lung cancer: tumor recurrence and overall survival.
Tantraworasin A; Saeteng S; Lertprasertsuke N; Arayawudhikul N; Kasemsarn C; Patumanond J
Cancer Manag Res; 2013; 5():327-36. PubMed ID: 24124391
[TBL] [Abstract][Full Text] [Related]
17. ERCC1, RRM1 and TUBB3 mRNA expression on the tumor response and overall survival of non-small cell lung cancer treated with platinum-based chemotherapy.
Qiao H; Huang X; Guo H; Liu Y; Yue C
Pak J Med Sci; 2014; 30(6):1403-8. PubMed ID: 25674147
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ERCC1, RRM1 and BRCA1 in surgically-treated patients with non-small cell lung cancer.
Pesta M; Kulda V; Fiala O; Safranek J; Topolcan O; Krakorova G; Cerny R; Pesek M
Anticancer Res; 2012 Nov; 32(11):5003-10. PubMed ID: 23155271
[TBL] [Abstract][Full Text] [Related]
19. Association between epidermal growth factor receptor mutations and the expression of excision repair cross-complementing protein 1 and ribonucleotide reductase subunit M1 mRNA in patients with non-small cell lung cancer.
Xu CW; Wang G; Wang WL; Gao WB; Han CJ; Gao JS; Li Y; Wang L; Zhang LY; Zhang YP; Tian YW; Fang JN
Exp Ther Med; 2015 Mar; 9(3):880-884. PubMed ID: 25667646
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers as prognostic factors for cN2 or 3 non-small cell lung cancer treated by induction chemoradiotherapy and surgery.
Yokomise H; Liu D; Chang S; Go T; Ishikawa S; Misaki N; Nakashima N
Anticancer Res; 2013 Mar; 33(3):1107-15. PubMed ID: 23482788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
